Director, CAR T Channel Strategy & Operations
Quick Summary
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company developing cell therapies for patients suffering from autoimmune diseases. Guided by our core values,
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company developing cell therapies for patients suffering from autoimmune diseases. Guided by our core values, Stay True to Why, Collaborate to Accelerate, Lead with Clarity, Boldly Innovative, and Own the Outcome, we are committed to transforming the future of treatment for autoimmune disease. Join us at the forefront of cell therapy innovation and help redefine what’s possible.
Kyverna is seeking Director, CAR T Channel Strategy & Operations. The Director, CAR T Channel Strategy & Operations is responsible for the development, execution, and continuous improvement of the commercial channel infrastructure supporting CAR T therapy delivery. This role provides strategic leadership for distribution, third-party logistics (3PL), specialty pharmacy strategy, state licensing, government pricing support, and channel governance activities. The position partners closely with Market Access, Commercial, Finance, Legal, Compliance, and Supply Chain teams to ensure scalable, compliant, and customer-focused channel operations that support current and future CAR T commercialization efforts.
Department: Commercial
Location: Remote eligible
Reports To: VP, Global Market Access
The national salary range for this position is from $190,000 to $230,000 USD annually. This salary range is an estimate of what we reasonably expect to pay for this posted position, and the actual salary may vary based on various factors, including without limitation individual education, experience, tenure, skills and abilities, as well as internal equity and alignment with market data. This position is also eligible for bonus, benefits, and participation in Company’s stock plan.
Location & Eligibility
Listing Details
- Posted
- June 12, 2026
- First seen
- June 12, 2026
- Last seen
- June 13, 2026
Posting Health
- Days active
- 0
- Repost count
- 0
- Trust Level
- 68%
- Scored at
- June 12, 2026
Signal breakdown

Kyverna Therapeutics is a biopharmaceutical company focused on developing innovative CAR T-cell therapies for autoimmune diseases.
View company profilePlease let Kyverna know you found this job on Jobera.
3 other jobs at Kyverna
View all →Explore open roles at Kyverna.
Similar Strategy & Operations jobs
View all →Browse Similar Jobs
Stay ahead of the market
Get the latest job openings, salary trends, and hiring insights delivered to your inbox every week.
No spam. Unsubscribe at any time.